WINNIPEG, Sept. 11 /CNW/ - IMRIS (TSX: IM) announced today the sale of
their flagship product, IMRISneuro, to one of the world's leading neuroscience
centers, The Johns Hopkins Hospital in Baltimore, Maryland.
IMRISneuro is a fully integrated operating room including the IMRIS
one-of-a kind, movable high field MRI. The new technology allows surgeons to
safely image patients in the operating room during brain surgery, helping to
rule out complications before the patient leaves the OR.
"The selection of IMRISneuro by a leading institution like Johns Hopkins
is another clear indication of the value our system offers, as well as its
growing acceptance as a mainstream product in neuroscience centers around the
world," said David Graves, President and Chief Executive Officer of IMRIS.
IMRIS (TSX: IM) is a global leader in providing fully integrated,
advanced surgical imaging solutions designed to measurably improve patient
outcomes. The company's flagship product, IMRISneuro, utilizes patented
technology that allows a high field MRI scanner to move in to the operating
room on demand, providing imaging during the surgical procedure without
compromising patient safety. This unique and innovative system has been
validated by leading neurosurgeons around the world for use in world-class
For more information, visit www.imris.com
About Johns Hopkins Hospital:
The Johns Hopkins Hospital has been ranked the number one hospital for 18
consecutive years in U.S. News & World Report's annual rankings of America's
best hospitals. In the magazine's specialty rankings, Johns Hopkins neurology
and neurosurgery have consistently ranked in the top two.
For further information:
For further information: Susan McLeod, Marketing Communications, IMRIS,
Tel: (204) 480-7094, Email: email@example.com